Meta-analysis of cerebrospinal fluid neuron-specific enolase levels in Alzheimer’s disease, Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy

被引:0
|
作者
Takayuki Katayama
Jun Sawada
Kae Takahashi
Osamu Yahara
Naoyuki Hasebe
机构
[1] Asahikawa City Hospital,Department of Neurology
[2] Asahikawa Medical University Hospital,Division of Neurology, First Department of Internal Medicine
关键词
Neuron-specific enolase; Cerebrospinal fluid; Alzheimer’s disease; Parkinson’s disease; Dementia with Lewy bodies; Multiple system atrophy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Meta-analysis of cerebrospinal fluid neuron-specific enolase levels in Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy
    Katayama, Takayuki
    Sawada, Jun
    Takahashi, Kae
    Yahara, Osamu
    Hasebe, Naoyuki
    ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
  • [2] Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE) in Alzheimer's disease
    Schmidt, Frank Martin
    Mergl, Roland
    Stach, Barbara
    Jahn, Ina
    Gertz, Hermann-Josef
    Schoenknecht, Peter
    NEUROSCIENCE LETTERS, 2014, 570 : 81 - 85
  • [3] Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?
    Palumbo, Barbara
    Siepi, Donatella
    Sabalich, Isabella
    Tranfaglia, Cristina
    Parnetti, Lucilla
    FUNCTIONAL NEUROLOGY, 2008, 23 (02) : 93 - 96
  • [4] Analysis of cerebrospinal fluid in dementia with Lewy bodies and Parkinson's disease dementia
    Mollenhauer, B
    Trenkwalder, C
    Sixel-Doering, F
    Bibl, M
    Canelo, M
    Schindehuette, J
    MOVEMENT DISORDERS, 2004, 19 : S246 - S246
  • [5] Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
    Oskar Hansson
    Sara Hall
    Annika Öhrfelt
    Henrik Zetterberg
    Kaj Blennow
    Lennart Minthon
    Katarina Nägga
    Elisabet Londos
    Shiji Varghese
    Nour K Majbour
    Abdulmonem Al-Hayani
    Omar MA El-Agnaf
    Alzheimer's Research & Therapy, 6
  • [6] Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease
    Hansson, Oskar
    Hall, Sara
    Ohrfelt, Annika
    Zetterberg, Henrik
    Blennow, Kaj
    Minthon, Lennart
    Nagga, Katarina
    Londos, Elisabet
    Varghese, Shiji
    Majbour, Nour K.
    Al-Hayani, Abdulmonem
    El-Agnaf, Omar M. A.
    ALZHEIMERS RESEARCH & THERAPY, 2014, 6 (03)
  • [7] Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are α-synucleinopathies
    Spillantini, MG
    PARKINSONISM & RELATED DISORDERS, 1999, 5 (04) : 157 - 162
  • [8] The α-synucleinopathies:: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy
    Spillantini, MG
    Goedert, M
    MOLECULAR BASIS OF DEMENTIA, 2000, 920 : 16 - 27
  • [9] Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies
    Parnetti, Lucilla
    Tiraboschi, Pietro
    Lanari, Alessia
    Peducci, Maria
    Padiglioni, Chiara
    D'Amore, Cataldo
    Pierguidi, Laura
    Tambasco, Nicola
    Rossi, Aroldo
    Calabresi, Paolo
    BIOLOGICAL PSYCHIATRY, 2008, 64 (10) : 850 - 855
  • [10] Analysis of Cerebrospinal Fluid Proteins in the Diagnosis of Parkinson's Disease, Parkinson Dementia and Dementia with Lewy Bodies
    Weinrich, C.
    Wrede, A.
    Mollenhauer, B.
    AKTUELLE NEUROLOGIE, 2011, 38 (04) : 203 - 210